Yvette Anderson MPS[/caption]
PSA’s projects make a bigger impact than ever before
The PSA released its 2025 Strategic Projects Impact Report last week, showcasing its leadership in advancing pharmacist practice.
Call for pharmacist access to the MBS for Chronic Disease Management
Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense.
After a...
Q&A: ‘I’m going overseas tomorrow . . . can you witness...
While pharmacists are now (very) familiar with rapid antigen tests (RATs) for COVID-19 testing, the practice of observed RATs for the purpose of international...
Treating hypertension – a new approach
Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians.
Research has indicated that a new pharmacological...
National Diabetes Week: now is the time to help people stay...
ADVERTORIAL BY GLUCERNA®
It can be challenging for those with impaired glucose tolerance or insulin resistance to maintain a healthy, low GI diet; especially considering...
An innovative, effective OTC solution to scalp pruritus
Dermal Therapy’s Scalp Relief range is clinically proven to relieve scalp itch and irritation in minutes. It is steroid- and tar-free and targets multiple common causes of itchy scalp.
